Ardis Callie on Standardisation and Documentation of VTE Risk Assessments
Ardis Callie, Research Assistant, Intersection of Australian Healthcare Standards and Clinical Governance, shared on LinkedIn:
”Quality Statement 1: Standardised and documented VTE risk assessments using an agreed risk tool on admission for all patients including day cases, would be a low cost, good start to VTE prevention.
That way, chemoprophylaxis could be provided in appropriate cases.
Sadly, surgeons I know, in some private hospitals at least, assume all day cases are low risk, don’t conduct VTE risk assessments, and prioritise short term bleeding risk and ignore the consequences for the patient when they go home (despite the national VTE Prevention Clinical Care Standard 2020).
Queensland Health follows a stricter 2018 guideline so patients should be in good hands in those facilities.
Comments welcome from those in the know.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026